Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications studying cancer adverse outcome nononcological therapies review food drug
… Dr. Riera has experience in clinical pharmacy, including drug distribution, central cytostatic preparation, … compounding of total parenteral nutrition, and therapeutic drug monitoring. During her PhD, Dr. Riera acquired … experience with large longitudinal studies from the German Cancer Research Center. At RTI-HS, she has provided …
… skin, sarcoma, and haematological cancers, targeted therapies as well as tumour-agnostic therapies), … Advisory Committee), and Canada (Canadian Agency for Drug and Technologies in Health, Canadian Drug Review). Dr. Wolowacz is a member of the editorial board for …
… ERA Heyes A, Millar L Transcript: We have conducted a review of publicly available information on scientific advice … price flexibility with the choice of a more limited expert review. Recently, NICE has communicated that there are …
CNS/Neurology A Wealth of Experience We have collaborated with our clients on projects to research central nervous system (CNS) and neurological diseases, CNS and neurologic treatment, and complications and comorbidities of CNS disease. Our experience …
… evidence dossiers and briefing books to support successful drug product labeling based on both novel and existing COA measures consistent with Food and Drug Administration guidance criteria. Over the … national meetings. She has also co-authored peer-reviewed publications in multiple disease areas summarizing the most …
… in marketing approvals for a number of prescription drug products. He has considerable regulatory experience, … having served as sponsor statistical representative at six Food and Drug Administration advisory committee meetings and numerous …
… Mordin regularly presents at conferences and has numerous publications in peer-reviewed journals, including the Journal … outcomes research for multiple medical devices, including drug/device combination products, transdermal delivery …
… of Treatment Alternatives OPPORTUNITY Disease-modifying therapies (DMTs) have been shown to reduce relapses and delay …
… in patients (pts) with early-stage non-small cell lung cancer (NSCLC): interim analysis of a global real-world study. …
… models (cost effectiveness, budget Impact) Drug utilization studies Epidemiology of disease Measurement …